Development of macrophage M2 relate signature for predicting prognosis and immunotherapy response in ovarian cancer.

Journal: Discover oncology
Published Date: May 13, 2025

Abstract

BACKGROUND: Ovarian cancer ranks as the fifth most common cause of cancer-related deaths in women worldwide. Macrophages M2 is believed to support tumor growth by suppressing immune responses and promoting angiogenesis.

Authors

  • Yifei Xiong
    Reproductive Medicine Center, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330000, China.
  • Yan Tong
    Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals